Follow-up Extension Study of Regular Physical Exercise in Patients With Symptomatic Intracranial Arterial Stenosis

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age40-80
SponsorCapital Medical University

About this trial

This study will include the subjects with symptomatic intracranial arterial stenosis (ICAS) who have participated in and completed the 1-year follow-up of RESIST trial (NCT06615726). The aim is to observe the long-term clinical outcomes over 3 years after a 1-year regular physical exercise intervention in patients with symptomatic ICAS.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Participants who enrolled in the RESIST trial and completed the 12-month follow-up.

Written informed consent to participate in this 3-year observational extension.

Disqualifiers

None

Trial population

This study will include the subjects who enrolled in the RESIST trial.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Non-Interventional Study

    Other intervention

    After completing 12-month intervention from RESIST trial, investigators would not make any interventions or impact on subjects.

Treatment groups

1,300 Participants
are divided into 2 treatment groups
Group A: Regular Physical Exercise Group1 intervention
Group B: Control Group1 intervention

Trial outcomes

Primary outcomes

1

New ischemic stroke events

Time frame
Within 3 years after randomization

Secondary outcomes

1

New ischemic stroke and transient ischemic attack events in the responsible vessel supply area

Time frame
Within 3 years after randomization
2

New ischemic stroke and transient ischemic attack events

Time frame
Within 3 years after randomization
3

Hemorrhagic stroke events

Time frame
Within 3 years after randomization
4

Myocardial infarction events

Time frame
Within 3 years after randomization

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.